StockData
DarioHealth Corp. logo

DarioHealth Corp. (DRIO) stock

DRIONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 8/3099% below fair value
$1.15−0.11 (-8.73%)

Close on Nov 16, 2026Market cap $11.27MP/E 0.3Yield –

DarioHealth enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

DarioHealth's enterprise value was $34.65M on Nov 10, 2026, against $79.52M a year earlier. Over the last 5 years it ranged from $24.66M to $4.23B, with a median of $694.76M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 10, 2026$34.65M-54.2%
2025Dec 31, 2025$75.73M-85.0%
2024Dec 31, 2024$505.78M-45.1%
2023Dec 29, 2023$921.32M-53.0%
2022Dec 30, 2022$1.96B-53.7%
2021Dec 31, 2021$4.23B+90.7%
2020Dec 31, 2020$2.22B+686.8%
2019Dec 31, 2019$281.98M+3286.8%
2018Dec 31, 2018$8.33M-15.9%
2017Dec 29, 2017$9.90M-34.0%
2016Dec 30, 2016$15.00M–
2015Dec 31, 2015-$884.03K–
2014Dec 31, 2014-$4.11M–
2013Dec 31, 2013-$4.19M–

More DarioHealth figures

See a number that looks wrong?